Molly He

Molly co-founded Element Biosciences and has served as Chief Executive Officer since its inception. She has more than 20 years of experience in technology innovation and management in biotechnology and healthcare industries, and has sponsored initiatives encompassing research and development, operations, and life cycle management.

Molly was previously a Venture Partner at Foresite Capital, investing in some of the most exciting and innovative companies in healthcare. Before then, she was Senior Director of Scientific Research at Illumina, responsible for Illumina’s global protein reagent innovation and improvements, and for leading global scientific and technical teams. She and her team have won twice the Innovation Award, the highest award for innovations with significant revenue impact at Illumina.

Prior to Illumina, Molly was the Head of Protein Sciences at Pacific Biosciences, where she was responsible for protein reagent development for their single-molecule real-time sequencing chemistry. She also has years of experience in the pharmaceutical industry, focusing on the structure-based design of antibody and small molecule drugs targeting cancer and immune diseases.

Molly holds a PhD from the University of California, Los Angeles in protein biophysics. She is passionate about science and technology education, has been a proud coach for the California State Science Olympiad competition since 2013.